Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.


Genetic and Rare Diseases Information Center (GARD)

Print friendly version

Ehlers-Danlos syndrome hypermobility type

Other Names for this Disease
  • EDS3 (formerly)
  • Ehlers-Danlos syndrome type 3 (formerly)
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.


What is Ehlers-Danlos syndrome (EDS) hypermobility type?

What are the signs and symptoms of Ehlers-Danlos syndrome (EDS) hypermobility type?

What causes Ehlers-Danlos syndrome (EDS) hypermobility type?

What is Ehlers-Danlos syndrome (EDS) hypermobility type?

Ehlers-Danlos syndrome hypermobility type is a connective tissue disorder that affects the tissues that support the skin, bones, blood vessels, and other organs. It is generally considered the least severe type of Ehlers-Danlos syndrome; however significant complications can occur. Symptoms include soft velvety skin, hyperextensible skin, dislocations, degenerative joint disease, chronic pain, and easy bruising. It is inherited in an autosomal dominant manner. In most cases the underlying genetic cause is unknown.[1]
Last updated: 1/19/2012

What are the signs and symptoms of Ehlers-Danlos syndrome (EDS) hypermobility type?

The signs and symptoms vary from mildly loose joints to musculoskeletal complications. Most often, this condition affects the joints and skin. An unusually large range of joint movement (hypermobility) is the most common symptom. Infants with hypermobile joints often appear to have weak muscle tone, which can delay the development of motor skills such as sitting, standing, and walking. The loose joints are unstable and prone to dislocation, chronic pain, and early-onset arthritis. Many people with Ehlers-Danlos syndrome have soft, velvety skin that is highly elastic (stretchy) and fragile. Affected individuals also tend to bruise easily.[2]
Last updated: 1/19/2012

What causes Ehlers-Danlos syndrome (EDS) hypermobility type?

While the causative gene in most individuals with EDS hypermobility type remains unknown and unmapped, a small percentage of people have been found to have mutations in the TNXB gene.[1][3]

These mutations prevent one copy of the TNXB gene from making any functional protein, reducing the total levels of tenascin-X in the body. Researchers believe that reduced levels of tenascin-X disturb the way that collagen is deposited and disrupt the network of elastic fibers in joint ligaments and tendons. Researchers have also discovered that not everyone with a mutation in one copy of TNXB has signs of Ehlers-Danlos syndrome.[3]

Some people with a condition called benign joint hypermobility syndrome (BJHS) also make a reduced amount of tenascin-X protein. This condition causes an unusually large range of joint movement (hypermobility) and chronic joint pain. The signs and symptoms of benign joint hypermobility syndrome overlap significantly with the features of the hypermobility type of Ehlers-Danlos syndrome. Recent studies suggest that they may be forms of the same condition.[3]

Some people with Ehlers-Danlos syndrome have mutations in two copies of the TNXB gene in each cell. These individuals have signs and symptoms similar to the classic type, but without the unusual scarring of the classic type. TNXB mutations prevent production of the tenascin-X protein, which disrupts the normal organization of collagen fibrils and elastic fibers. These changes in the structure of connective tissue likely cause the characteristic features of classic Ehlers-Danlos syndrome.[3]

Testing for TNXB mutations is available on a limited clinical basis.[1]

Last updated: 4/22/2013

  1. Levy HP. Ehlers-Danlos syndrome, hypermobility type. GeneReviews. December 2010; Accessed 4/22/2013.
  2. Ehlers-Danlos syndrome. Genetics Home Reference. May 2006; Accessed 1/19/2012.
  3. TNXB. Genetics Home Reference (GHR). May 2006; Accessed 4/22/2013.